ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

About this update from Ani Pharmaceuticals, Inc.

PRINCETON, N.J. , Nov. 04, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani , President and Chief Executive Officer, and Stephen Carey , Chief Financial Officer, will present at at two upcoming investor conferences as follows: • The Guggenheim Inaugural Healthcare Innovation Conference Wednesday, November 13, 2024 , at 10:00am ET • The Jefferies London Healthcare Conference Wednesday, November 20, 2024 , at 2:30pm GMT / 9:30am ET The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com , under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S. -based manufacturing; and its Established Brands business. For more information, visit www.anipharmaceuticals.com . Investor Relations: Lisa M. Wilson , In-Site Communications, Inc. T: 212-452-2793 E: [email protected] Source: ANI Pharmaceuticals, Inc. Source: ANI Pharmaceuticals, Inc.

View stock analysis, news, and events for Ani Pharmaceuticals, Inc.